Development and validation of an LC-MS/MS method for simultaneous determination of EVT201 and its five metabolites in human plasma: Application to a clinical study in Chinese healthy subjects

化学 色谱法 药代动力学 选择性反应监测 高效液相色谱法 电喷雾 定量分析(化学) 电喷雾电离 质谱法 串联质谱法 药理学 医学
作者
Xinrui Zhang,Shunbo Zhao,Tao Wang,Chang Shu,Li Ding
出处
期刊:Journal of Pharmaceutical and Biomedical Analysis [Elsevier BV]
卷期号:235: 115601-115601 被引量:1
标识
DOI:10.1016/j.jpba.2023.115601
摘要

EVT201 is a partial GABAA receptor agonist, which inhibits nervous system to treat insomnia. EVT201 can form a variety of metabolites in vivo including Ro46–1927, Ro18–5528, Ro40–9970, Ro66–9196 and Ro66–5448. This study developed a simple method to realize the simultaneous determination of EVT201 and its five metabolites by HPLC-MS/MS with an electrospray ion source (ESI). The deuterium substitute of EVT201 was chosen as the internal standard and the multiple reaction monitoring (MRM) was used for the quantification. The separation of the six compounds was accomplished with an ACE Excel 3 AQ column (50 × 2.1 mm, 3 µm, ACE). The process of protein precipitating-transferring-nitrogen blowing-reconstituting was adopted for the sample pretreatment. This method was successfully validated according to the FDA guidance. Calibration curves were linear over the concentration range of 0.100–100 ng/mL for EVT201, 0.0300–30.0 ng/mL for Ro46–1927, 0.0600–6.00 ng/mL for Ro18–5528, 0.0200–4.00 ng/mL for Ro40–9970, 0.100–20.0 ng/mL for Ro66–9196 and 0.100–20.0 ng/mL for Ro66–5448. The intra-run and inter-run precisions and accuracies were all within 14.5%. This fully validated method was successfully applied to a clinical pharmacokinetic study of EVT201 and its five metabolites in Chinese healthy subjects after the single (2.5 mg and 5 mg, N = 12) and multiple dose (2.5 mg, N = 13) administration of EVT201 capsules. The test results of 2.5 mg dose group showed that for EVT201, Ro46–1927, Ro18–5528, Ro40–9970, Ro66–9196 and Ro66–5448, the Cmax values (ng/mL) were 39.2 ± 9.2, 10.3 ± 1.4, 0.218 ± 0.044, 0.128 ± 0.051, 7.01 ± 1.51, 8.73 ± 3.69, respectively; the AUC0−t values (h·ng/mL) were 231 ± 79, 143 ± 72, 10.9 ± 2.1, 1.84 ± 0.78, 55.9 ± 18.7, 135 ± 40 respectively. For EVT201, Ro46–1927, Ro66–5528, Ro66–9196 and Ro40–5448, the results of Cmax and AUC0−t proved that the five compounds showed linear pharmacokinetic profile over the dose ranges of 2.5 mg to 5 mg. Meanwhile, it is the first report to evaluate the pharmacokinetic characteristics of Ro40–9970, Ro66–9196 and Ro66–5448 in human plasma. It provided meaningful parameters for the safety and tolerability evaluation of EVT201 capsules in human.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
QQ完成签到,获得积分10
1秒前
桐桐的应助被合适的吐司采纳,获得10
1秒前
1秒前
1秒前
3秒前
3秒前
4秒前
Jio-PPx完成签到,获得积分10
5秒前
6秒前
苏小咩发布了新的文献求助10
6秒前
6秒前
王禹垚发布了新的文献求助10
7秒前
袋袋发布了新的文献求助10
7秒前
8秒前
NY发布了新的文献求助10
8秒前
lyj发布了新的文献求助10
8秒前
所所的应助被qd采纳,获得10
9秒前
10秒前
科研通AI6.3的应助被lmy采纳,获得10
10秒前
zhudaxia完成签到,获得积分10
12秒前
12秒前
12秒前
花痴的手套完成签到 ,获得积分10
12秒前
麦粑块发布了新的文献求助10
13秒前
小牛牛发布了新的文献求助10
13秒前
13秒前
15秒前
INT发布了新的文献求助10
16秒前
hyy发布了新的文献求助30
16秒前
研友_VZG7GZ的应助被李瑞程采纳,获得10
16秒前
小蘑菇的应助被醉熏的寄松采纳,获得10
17秒前
我是谁的应助被醉熏的寄松采纳,获得50
17秒前
zhudaxia发布了新的文献求助30
17秒前
领导范儿的应助被醉熏的寄松采纳,获得10
17秒前
慕青的应助被醉熏的寄松采纳,获得10
17秒前
无花果的应助被醉熏的寄松采纳,获得10
17秒前
Lucas的应助被醉熏的寄松采纳,获得10
17秒前
国服躺赢完成签到,获得积分10
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183263
求助须知:如何正确求助?哪些是违规求助? 9572532
关于积分的说明 21826339
捐赠科研通 7780187
什么是DOI,文献DOI怎么找? 3433993
关于科研通互助平台的介绍 2558131
邀请新用户注册赠送积分活动 2480239